| 000 | 00947 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517003419.0 | ||
| 264 | 0 | _c20150727 | |
| 008 | 201507s 0 0 eng d | ||
| 022 | _a1757-4684 | ||
| 024 | 7 |
_a10.15252/emmm.201404596 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHuber, Margit A | |
| 245 | 0 | 0 |
_aKey drivers of biomedical innovation in cancer drug discovery. _h[electronic resource] |
| 260 |
_bEMBO molecular medicine _cJan 2015 |
||
| 300 |
_a12-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aBiomedical Research |
| 650 | 0 | 4 | _aDrug Discovery |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 700 | 1 | _aKraut, Norbert | |
| 773 | 0 |
_tEMBO molecular medicine _gvol. 7 _gno. 1 _gp. 12-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.15252/emmm.201404596 _zAvailable from publisher's website |
| 999 |
_c24377956 _d24377956 |
||